1 / 25

“Accessibility of Protected Inventions and Plant varieties for Further Innovations”

“Accessibility of Protected Inventions and Plant varieties for Further Innovations”. Victoria Henson-Apollonio, Ph.D.,Manager, the CGIAR Central Advisory Service on IP. Introduction. Patent Protection for Plant Inventions Exceptions to Infringement.

Download Presentation

“Accessibility of Protected Inventions and Plant varieties for Further Innovations”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. “Accessibility of Protected Inventions and Plant varieties for Further Innovations” Victoria Henson-Apollonio, Ph.D.,Manager, the CGIAR Central Advisory Service on IP

  2. Introduction • Patent Protection for Plant Inventions • Exceptions to Infringement

  3. Patent options for protection of plant material • Plant Patents • Utility Patents • Standard Patents

  4. Plant Patent option • Unique to U.S. • Oldest type of statutory IP protection for living material, --Townsend-Parnell Plant Patent Act, 46 Stat. 376 (May 23, 1930, ch. 312, §1).

  5. Plant Patent option • One claim, describing unique new characteristics • Protects asexually reproduced plants • Favored for protection of new horticultural varieties, as well as fruit and nut trees • No Tuberous plants

  6. Utility Patent option • Original Patent Act, 1790 • U.S. option for inventions- process, machine, manufacture, composition of matter • Right to exclude others from making, using, selling, (importing), the claimed invention –in/into the U.S.

  7. Utility Patent option • Invention must be novel, non-obvious and useful • Inventions involving living material, --Chakrabarty case –U.S. Supreme Court ruling in 1980, –”..anything under the sun that is made by man.”

  8. Utility Patent option • Multiple aspects of a plant invention can be claimed • “Best mode disclosure” and “enablement” requirements • Often met by deposit of propagative material into a “Budapest” –certified depository

  9. Utility Patent option • Applicant can file applications for rights on the same variety, under both the utility patent regulations as well as under the Plant Variety Protection Act

  10. Standard Patent option- EPO • European Patent Office practice (European Patent Convention) • National laws interpret European Parliament Directives

  11. Standard Patent option-EPO • Original EPO interpretation of Directive 98/44/EC –no basis for patents on living plants • Overturned by decision in late 1999, that a claim directed to transgenic plants of more that one variety, that does not claim an individual plant variety, is permissible.

  12. Standard Patent option-Japan • Japan allows claims directed to plants and to the genetic engineering of plants • Claims tend to be very narrow

  13. Standard Patent --Australia • Claims can be directed to new plant varieties, plants components, reproductive material, products from plants and plant materials used in industrial processes

  14. Standard/Utility Patent –New Zealand • Claims can be directed to new transgenic plant varieties, plants components

  15. Exceptions to Infringement-U.S. • Plant Patents (U.S.) —can be used as breeding material (Judicial) • Utility Patents (U.S.) –Very narrow interpretation • Further-narrowed by recent (Oct 10, 2002) ruling --Madey v Duke University

  16. Exceptions to Infringement—U.S. • Madey v. Duke University also narrowed the definition of “non-commercial” • Pharmaceutical industry in U.S. enjoys a “safe harbor” provided by the U.S. Legislature–the Bolar Amendment (Section 271(e))—allows generic drug makers to test versions of patented drug for regulatory approval

  17. Exceptions to Infringement-EU • Community Patent Convention Article 27(b) (currently, non-binding),provides that, “the rights conferred by a patent shall not extend to acts done for experimental purposes relating to the subject matter of the patented invention.”

  18. Exceptions to Infringement-EU • Standard Patents- Experimental use exception in U.K. patent law (Section 60(5)(b) • German Courts have interpreted the experimental use clause in the patent law, quite liberally –at least in pharma cases

  19. Exceptions to Infringement-Japan • Experimental use exception provided by Section 69 (1) of the Japanese Patent Law. • Scant case law, so far, to aid in interpretation of experimental use exception dealing with plants

  20. Contract options for “enlarging” research exemption • Through collaborative agreements–Collaborator may have license • Bilateral contract/license with patent owner

  21. Contract options for “enlarging” research exemption • Cross-licensing • “Patent Pooling”/”Clearing-House” mechanisms

  22. Summary • Several patent instruments covering plant inventions – • Primarily used by inventors in developed countries • Experimental use/Research exceptions to infringement do exist

  23. Summary • Exceptions is U.S. are mainly judicially created • U.S. exceptions are very narrow • European and Japanese exceptions tend to be legislated and are interpreted fairly broadly

  24. Summary • “Research only” licenses are usually, but not always, available to public institutions • Other contract options/arrangements have been used

  25. The CGIAR Central Advisory Service on Intellectual Property,Housed at ISNAR in The Haguev.henson-apollonio@cgiar.org

More Related